Open Access131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
Author(s) -
Qiang He,
Wusheng Lu,
Yang Liu,
Yong-Song Guan,
Anren Kuang
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i47.9104
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , transcatheter arterial chemoembolization , adverse effect , incidence (geometry) , toxicity , blood test , carcinoma , surgery , physics , optics
To investigate the safety and effectiveness of combined (131)I-metuximab and transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).